[生长抑素类似物（奥曲肽）] - Suppr

Suppr

超能文献

[Somatostatin analogue (octreotide)].

作者信息

Sano K, Makuuchi M

机构信息

Division of Hepato-Biliary-Pancreatic Surgery, Graduate School of Medicine, University of Tokyo.

出版信息

Nihon Rinsho. 2001 Oct;59 Suppl 6:674-7.

PMID:11762035

Abstract

摘要

相似文献

[Somatostatin analogue (octreotide)].

Nihon Rinsho. 2001 Oct;59 Suppl 6:674-7.

Octreotide and hepatocellular carcinoma.

Br J Cancer. 2007 Jun 4;96(11):1778-9. doi: 10.1038/sj.bjc.6603799. Epub 2007 May 15.

[A therapeutic study of hepatocellular carcinoma using octreotide (HECTOR). Hepatocellular Carcinoma: Treatment with Octreotide].

Dtsch Med Wochenschr. 2000 Mar 17;125(11):320.

The results of a randomized study on the use of long-acting octreotide in hepatocellular carcinoma.

Hepatology. 2003 Feb;37(2):477-8; author reply 478. doi: 10.1053/jhep.2003.50027.

Octreotide treatment of hepatocellular carcinoma.

Hepatology. 2003 Feb;37(2):477. doi: 10.1053/jhep.2003.50026.

Octreotide in hepatocellular carcinoma.

Gut. 1998 Mar;42(3):316-7. doi: 10.1136/gut.42.3.316.

Long-acting octreotide versus placebo for treatment of advanced HCC: a randomized controlled double-blind study.

Hepatology. 2007 Jan;45(1):9-15. doi: 10.1002/hep.21468.

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study.

Gut. 1998 Mar;42(3):442-7. doi: 10.1136/gut.42.3.442.

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide.

Br J Cancer. 2006 Oct 9;95(7):853-61. doi: 10.1038/sj.bjc.6603325. Epub 2006 Sep 5.

Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment.

J Clin Oncol. 2007 Jun 1;25(16):e15-6. doi: 10.1200/JCO.2006.09.5760.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Somatostatin analogue (octreotide)].

作者信息

Sano K, Makuuchi M

机构信息

Division of Hepato-Biliary-Pancreatic Surgery, Graduate School of Medicine, University of Tokyo.

出版信息

Nihon Rinsho. 2001 Oct;59 Suppl 6:674-7.

PMID:11762035

Abstract

摘要

相似文献

[Somatostatin analogue (octreotide)].

Nihon Rinsho. 2001 Oct;59 Suppl 6:674-7.

Octreotide and hepatocellular carcinoma.

Br J Cancer. 2007 Jun 4;96(11):1778-9. doi: 10.1038/sj.bjc.6603799. Epub 2007 May 15.

[A therapeutic study of hepatocellular carcinoma using octreotide (HECTOR). Hepatocellular Carcinoma: Treatment with Octreotide].

Dtsch Med Wochenschr. 2000 Mar 17;125(11):320.

The results of a randomized study on the use of long-acting octreotide in hepatocellular carcinoma.

Hepatology. 2003 Feb;37(2):477-8; author reply 478. doi: 10.1053/jhep.2003.50027.

Octreotide treatment of hepatocellular carcinoma.

Hepatology. 2003 Feb;37(2):477. doi: 10.1053/jhep.2003.50026.

Octreotide in hepatocellular carcinoma.

Gut. 1998 Mar;42(3):316-7. doi: 10.1136/gut.42.3.316.

Long-acting octreotide versus placebo for treatment of advanced HCC: a randomized controlled double-blind study.

Hepatology. 2007 Jan;45(1):9-15. doi: 10.1002/hep.21468.

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study.

Gut. 1998 Mar;42(3):442-7. doi: 10.1136/gut.42.3.442.

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide.

Br J Cancer. 2006 Oct 9;95(7):853-61. doi: 10.1038/sj.bjc.6603325. Epub 2006 Sep 5.

Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment.

J Clin Oncol. 2007 Jun 1;25(16):e15-6. doi: 10.1200/JCO.2006.09.5760.